Merck (MRK) Leases (2019 - 2024)
Historic Leases for Merck (MRK) over the last 6 years, with Q4 2024 value amounting to $1.4 billion.
- Merck's Leases fell 466.25% to $1.4 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 billion, marking a year-over-year decrease of 466.25%. This contributed to the annual value of $1.4 billion for FY2024, which is 466.25% down from last year.
- Latest data reveals that Merck reported Leases of $1.4 billion as of Q4 2024, which was down 466.25% from $1.4 billion recorded in Q4 2023.
- In the past 5 years, Merck's Leases ranged from a high of $1.7 billion in Q4 2020 and a low of $1.3 billion during Q4 2022
- In the last 5 years, Merck's Leases had a median value of $1.4 billion in 2023 and averaged $1.5 billion.
- As far as peak fluctuations go, Merck's Leases surged by 5731.59% in 2020, and later tumbled by 1513.24% in 2022.
- Merck's Leases (Quarter) stood at $1.7 billion in 2020, then decreased by 6.04% to $1.6 billion in 2021, then decreased by 15.13% to $1.3 billion in 2022, then rose by 6.76% to $1.4 billion in 2023, then decreased by 4.66% to $1.4 billion in 2024.
- Its last three reported values are $1.4 billion in Q4 2024, $1.4 billion for Q4 2023, and $1.3 billion during Q4 2022.